Appili Therapeutics (Appili Therapeutics) Total Liabilities : $8.80 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Total Liabilities?

Appili Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 was $8.80 Mil.

Appili Therapeutics's quarterly Total Liabilities increased from Jun. 2023 ($8.23 Mil) to Sep. 2023 ($8.61 Mil) and increased from Sep. 2023 ($8.61 Mil) to Dec. 2023 ($8.80 Mil).

Appili Therapeutics's annual Total Liabilities increased from Mar. 2021 ($4.43 Mil) to Mar. 2022 ($9.13 Mil) but then declined from Mar. 2022 ($9.13 Mil) to Mar. 2023 ($7.70 Mil).

Appili Therapeutics Total Liabilities Historical Data

The historical data trend for Appili Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Total Liabilities Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

1.81

1.67

4.43

9.13

7.70

Appili Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															5.85	7.70	8.23	8.61	8.80

Appili Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Appili Therapeutics's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.176	+	(5.519	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.70

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	2.289	-	-5.406
	=	7.70

Appili Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.137	+	(5.659	+	-0.0010000000000003
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	8.80

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	1.467	-	-7.328
	=	8.80

Appili Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics (Appili Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.